| |
 |
|
Class Information
Number: 424/258.1
Name: Drug, bio-affecting and body treating compositions > Antigen, epitope, or other immunospecific immunoeffector (e.g., immunospecific vaccine, immunospecific stimulator of cell-mediated immunity, immunospecific tolerogen, immunospecific immunosuppressor, etc.) > Bacterium or component thereof or substance produced by said bacterium (e.g., legionella, borrelia, anaplasma, shigella, etc.) > Salmonella (e.g., salmonella typhimurium, etc.)
Description: Subject matter wherein the bacterium is of the genus Salmonella.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7371393 |
Methods for reducing fecal shedding |
May. 13, 2008 |
| 7354592 |
Genetically modified tumor-targeted bacteria with reduced virulence |
Apr. 8, 2008 |
| 7341732 |
Methods for treating mastitis in a milk producing animal |
Mar. 11, 2008 |
| 7297338 |
Avian vaccine composition for the protection of poultry against disease and infection caused by E. coli and Salmonella |
Nov. 20, 2007 |
| 7255851 |
Non-invasive localization of a light-emitting conjugate in a mammal |
Aug. 14, 2007 |
| 7211264 |
Attenuated microorganisms for the treatment of infection |
May. 1, 2007 |
| 7198774 |
Non-invasive localization of a light-emitting conjugate in a mammal |
Apr. 3, 2007 |
| 7160549 |
Methods for making compositions including gram negative microbial polypeptides |
Jan. 9, 2007 |
| 7147857 |
Methods for treating high somatic cell counts |
Dec. 12, 2006 |
| 7138125 |
Methods for treating an animal for low milk production |
Nov. 21, 2006 |
| 7138124 |
Polypeptides obtained from gram negative microbes |
Nov. 21, 2006 |
| 7132108 |
Biodegradable and biocompatible polymeric microspheres encapsulating Salmonella enteritidis bacteria |
Nov. 7, 2006 |
| 7115269 |
Attenuated Salmonella strain used as a vehicle for oral immunization |
Oct. 3, 2006 |
| 7101555 |
Mycobacterial proteins, microorganisms producing them and their use for vaccines and the detection of tuberculosis |
Sep. 5, 2006 |
| 7083794 |
Recombinant vaccines comprising immunogenic attenuated bacteria having RpoS positive phenotype |
Aug. 1, 2006 |
| 7045122 |
Salmonella vaccine |
May. 16, 2006 |
| 7029678 |
Vaccines |
Apr. 18, 2006 |
| 6969513 |
Plasmid maintenance system for antigen delivery |
Nov. 29, 2005 |
| 6951652 |
Vaccine for prevention of gram-negative bacterial infections and endotoxin related diseases |
Oct. 4, 2005 |
| 6923972 |
Methods for use of genetically modified tumor-targeted bacteria with reduced virulence |
Aug. 2, 2005 |
| 6905691 |
Vaccines containing attenuated bacteria |
Jun. 14, 2005 |
| 6872547 |
Functional balanced-lethal host-vector systems |
Mar. 29, 2005 |
| 6863894 |
Genetically modified tumor-targeted bacteria with reduced virulence |
Mar. 8, 2005 |
| 6861247 |
Salmonella secreted proteins and uses thereof |
Mar. 1, 2005 |
| 6858211 |
Vaccines against Escherichia coli O157 infection |
Feb. 22, 2005 |
| 6846488 |
Chimeric antigen-enterotoxin mucosal immunogens |
Jan. 25, 2005 |
| 6844423 |
Compositions and methods for regulating bacterial pathogenesis |
Jan. 18, 2005 |
| 6797275 |
Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine |
Sep. 28, 2004 |
| 6783765 |
Process for the preparation of a vaccine for the treatment of tuberculosis and other intracellular infections diseases and the vaccine produced by the process |
Aug. 31, 2004 |
| 6764687 |
Live attenuated bacteria for use in a vaccine |
Jul. 20, 2004 |
| 6756042 |
Attenuated microorganisms for the treatment of infection |
Jun. 29, 2004 |
| 6749831 |
Vaccine against lipopolysaccharide core |
Jun. 15, 2004 |
| 6743607 |
Production of complex carbohydrates |
Jun. 1, 2004 |
| 6713073 |
Method of vaccination of newly hatched poultry |
Mar. 30, 2004 |
| 6680182 |
Expression of recombinant fusion proteins in attenuated bacteria |
Jan. 20, 2004 |
| 6676945 |
Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
Jan. 13, 2004 |
| 6656478 |
Cross-protective salmonella vaccines |
Dec. 2, 2003 |
| 6656479 |
Attenuated live neospora vaccine |
Dec. 2, 2003 |
| 6623739 |
Vaccines |
Sep. 23, 2003 |
| 6613321 |
Live vaccines against gram-negative pathogens, expressing heterologous O-antigens |
Sep. 2, 2003 |
| 6610529 |
Recombinant bacterial system with environmentally limited viability |
Aug. 26, 2003 |
| 6605286 |
Delivery of biologically active polypeptides |
Aug. 12, 2003 |
| 6605285 |
Vaccine for protection of poultry against salmonellosis and a process for preparing the same |
Aug. 12, 2003 |
| 6562349 |
Otitis media vaccine |
May. 13, 2003 |
| 6548287 |
Non-pyrogenic bacterial strains and use of the same |
Apr. 15, 2003 |
| 6537558 |
Methods of producing and using virulence attenuated poxR mutant bacteria |
Mar. 25, 2003 |
| 6495334 |
Recombinant Sef14 fimbrial protein from Salmonella |
Dec. 17, 2002 |
| 6479056 |
Live vaccine constituting minor risk for humans |
Nov. 12, 2002 |
| 6475482 |
Genetically modified tumor-targeted bacteria with reduce virulence |
Nov. 5, 2002 |
| 6458368 |
Attenuated microorganism strains expressing HPV proteins |
Oct. 1, 2002 |
|
|
|
